Fulphila

Active Ingredient(s): Pegfilgrastim-jmdb
FDA Approved: * June 4, 2018
Pharm Company: * MYLAN GMBH
Category: Cancer

Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.[5] It serves to stimulate the production of white blood cells (neutrophils).[5][7] Pegfilgrastim was developed by Amgen.[8] Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemo... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Fulphila 6 mg/.6ml Subcutaneous Injection
NDC: 67457-833
Labeler:
Mylan Institutional LLC
Fulphila 6 mg/.6ml Subcutaneous Injection
NDC: 83257-005
Labeler:
Biocon Biologics Inc.

Related Brands

Drugs with the same active ingredients